INNV vs. CORT
INNV (InnovAge Holding Corp.) and CORT (Corcept Therapeutics Incorporated) are both stocks. Both are in the Healthcare sector — INNV in Medical Care Facilities, CORT in Biotechnology. Over the past 5 years, INNV returned -7.59%/yr vs 40.69%/yr for CORT. Their 0.20 correlation means their historical movements had little consistent relationship.
Performance
INNV vs. CORT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INNV achieves a 118.88% return, which is significantly lower than CORT's 228.99% return.
INNV
- 1D
- -2.07%
- 1M
- -5.25%
- 6M
- 104.68%
- YTD
- 118.88%
- 1Y
- 262.94%
- 3Y*
- 18.02%
- 5Y*
- -7.59%
- 10Y*
- —
- ALL TIME*
- -12.92%
CORT
- 1D
- -3.24%
- 1M
- 26.91%
- 6M
- 187.16%
- YTD
- 228.99%
- 1Y
- 65.93%
- 3Y*
- 66.06%
- 5Y*
- 40.69%
- 10Y*
- 35.35%
- ALL TIME*
- 10.54%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $163.77M | $133.02M | $94.73M | |
| $2.95M | $3.34M | $3.45M |
INNV vs. CORT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
INNV InnovAge Holding Corp. | 118.88% | 32.06% | -34.50% | -16.43% | 43.60% | -79.17% |
CORT Corcept Therapeutics Incorporated | 228.99% | -30.94% | 55.14% | 59.92% | 2.58% | -18.89% |
Correlation
The correlation between INNV and CORT is 0.10, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.10 |
Correlation (3Y) Balances recent behavior with more history. | 0.17 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.20 |
Correlation (All Time) Calculated using the full available price history since Mar 4, 2021 | 0.20 |
The correlation between INNV and CORT shifts across timeframes, from 0.10 (1 year) to 0.20 (all time), reflecting how their relationship changes across market environments.
Fundamentals
INNV:
$1.54B
CORT:
$12.29B
INNV:
-$0.16
CORT:
$0.48
INNV:
1.63
CORT:
15.92
INNV:
6.62
CORT:
19.20
INNV:
$945.90M
CORT:
$830.81M
INNV:
$140.05M
CORT:
$816.73M
INNV:
$5.26M
CORT:
$23.30M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INNV vs. CORT — Risk / Return Rank
INNV
CORT
INNV vs. CORT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for InnovAge Holding Corp. (INNV) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| INNV | CORT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.09 | ||
| Sortino ratioReturn per unit of downside risk | +1.97 | ||
| Omega ratioGain probability vs. loss probability | 1.42 | 1.31 | +0.10 |
| Calmar ratioReturn relative to maximum drawdown | 7.34 | 1.10 | +6.24 |
| Martin ratioReturn relative to average drawdown | 15.83 | 2.01 | +13.83 |
Loading charts...
Drawdowns
INNV vs. CORT - Drawdown Comparison
The maximum INNV drawdown since its inception was -89.92%, roughly equal to the maximum CORT drawdown of -94.29%. Use the drawdown chart below to compare losses from any high point for INNV and CORT.
Loading charts...
Drawdown Indicators
| INNV | CORT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.92% | -94.29% | +4.37% |
Max Drawdown (1Y)Largest decline over 1 year | -33.21% | -64.40% | +31.19% |
Max Drawdown (3Y)Largest decline over 3 years | -65.42% | -71.85% | +6.43% |
Max Drawdown (5Y)Largest decline over 5 years | -84.76% | -71.85% | -12.91% |
Max Drawdown (10Y)Largest decline over 10 years | — | -71.85% | — |
Current DrawdownCurrent decline from peak | -56.37% | -3.24% | -53.13% |
Average DrawdownAverage peak-to-trough decline | -71.97% | -53.26% | -18.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.37% | 35.24% | -19.87% |
Volatility
INNV vs. CORT - Volatility Comparison
The current volatility for InnovAge Holding Corp. (INNV) is 13.88%, while Corcept Therapeutics Incorporated (CORT) has a volatility of 28.47%. This indicates that INNV experiences smaller price fluctuations and is considered to be less risky than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INNV | CORT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.88% | 28.47% | -14.59% |
Volatility (6M)Calculated over the trailing 6-month period | 51.14% | 48.65% | +2.49% |
Volatility (1Y)Calculated over the trailing 1-year period | 82.81% | 82.04% | +0.77% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 74.83% | 75.77% | -0.94% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 72.87% | 67.83% | +5.04% |
Dividends
INNV vs. CORT - Dividend Comparison
Neither INNV nor CORT has paid dividends to shareholders.
Financials
INNV vs. CORT - Financials Comparison
This section allows you to compare key financial metrics between InnovAge Holding Corp. and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
INNV vs. CORT - Profitability Comparison
INNV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, InnovAge Holding Corp. reported a gross profit of 0.00 and revenue of 251.94M. Therefore, the gross margin over that period was 0.0%.
CORT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Corcept Therapeutics Incorporated reported a gross profit of 252.09M and revenue of 256.15M. Therefore, the gross margin over that period was 98.4%.
INNV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, InnovAge Holding Corp. reported an operating income of 0.00 and revenue of 251.94M, resulting in an operating margin of 0.0%.
CORT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Corcept Therapeutics Incorporated reported an operating income of 41.30M and revenue of 256.15M, resulting in an operating margin of 16.1%.
INNV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, InnovAge Holding Corp. reported a net income of -29.46M and revenue of 251.94M, resulting in a net margin of -11.7%.
CORT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Corcept Therapeutics Incorporated reported a net income of 42.14M and revenue of 256.15M, resulting in a net margin of 16.5%.
Frequently Asked Questions
INNV and CORT have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CORT has higher volatility (28.47%) compared to INNV (13.88%). In terms of maximum drawdown, INNV dropped -89.92% vs CORT's -94.29%.
INNV currently has the higher Sharpe Ratio (2.96 vs 0.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INNV and CORT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer